Cargando…
Lipoprotein(a): Cardiovascular Disease, Aortic Stenosis and New Therapeutic Option
Atherosclerosis is a chronic and progressive inflammatory process beginning early in life with late clinical manifestation. This slow pathological trend underlines the importance to early identify high-risk patients and to treat intensively risk factors to prevent the onset and/or the progression of...
Autores principales: | Maloberti, Alessandro, Fabbri, Saverio, Colombo, Valentina, Gualini, Elena, Monticelli, Massimiliano, Daus, Francesca, Busti, Andrea, Galasso, Michele, De Censi, Lorenzo, Algeri, Michela, Merlini, Piera Angelica, Giannattasio, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820656/ https://www.ncbi.nlm.nih.gov/pubmed/36613613 http://dx.doi.org/10.3390/ijms24010170 |
Ejemplares similares
-
Endothelial Dysfunction in Patients with Advanced Heart Failure Treated with Levosimendan Periodic Infusion Compared with Optimal Medical Therapy: A Pilot Study
por: Maloberti, Alessandro, et al.
Publicado: (2022) -
COVID-19 and cardiovascular system: Not only heart but also vascular. The effects of the infection on arterial stiffness
por: Maloberti, A., et al.
Publicado: (2022) -
Acupuncture in Arterial Hypertension: Evaluation of its Efficacy with Both Office and Ambulatory Blood Pressure Measurements
por: Migliarese, Cristina, et al.
Publicado: (2022) -
Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients
por: Maloberti, Alessandro, et al.
Publicado: (2022) -
Lipoprotein(a) as Orchestrator of Calcific Aortic Valve Stenosis
por: Schnitzler, Johan G., et al.
Publicado: (2019)